40
Participants
Start Date
November 30, 2014
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
myo-inositol
myo-inositol, oral, 2g, twice a day for 5 days total
Continuous glucose monitoring surveillance
monitoring device will be placed by experienced research members to the patient on Day 1 and she will continue to wear until Day 7. This device monitors overall glycemia every 5 minutes and records the information, which can be downloaded after discontinued.
Glucose monitoring
patients will use the glucose meter, test strips, and lancets to determine her capillary glucose levels 4 times per day (fasting, and 1 hour post-prandial levels)
RECRUITING
Oregon Health and Science University, Portland
Collaborators (1)
Duke University
OTHER
Washington University School of Medicine
OTHER
Oregon Health and Science University
OTHER